Nuzenio

Cartesian Therapeutics Reports

Cartesian Therapeutics Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 11:00:00 GMTFour new employees get options for 115,250 Cartesian shares - Stock Titan
Thu, 06 Aug 2026 14:48:34 GMTCartesian Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Thu, 06 Aug 2026 11:15:00 GMTCartesian Therapeutics Reports Q2 2026 Results, Advances Descartes-08 Clinical Trials and WestGene In Vivo Partnership - Quiver Quantitative
Thu, 06 Aug 2026 11:13:01 GMTCartesian Therapeutics reports Q2 2026: $149.3M cash; net income $15.8M; Phase 3 MG data expected 1Q27 - TradingView
Thu, 06 Aug 2026 11:06:28 GMTCartesian Therapeutics (Nasdaq: RNAC) Q2 earnings boosted by CVR revaluation - Stock Titan
Fri, 31 Jul 2026 07:00:00 GMTCartesian Therapeutics (NASDAQ:RNAC) Raised to Hold at Zacks Research - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Cartesian Therapeutics Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.